Blood Typing Market By Type (Blood Typing Reagents, Blood Typing Kits, Blood Typing Instruments, Services, Others), By Technology (Serological Testing, Gel Card Technology, Molecular Testing, Microarray-based Testing, Automated Blood Typing Systems, Others), By Sample Type (Whole Blood, Red Blood Cells, Plasma, Serum, Others), By Application (Transfusion Medicine, Organ Transplantation, Forensic Science, Prenatal Testing, Disease Screening, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Research & Academic Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape the Blood Typing Market in the coming years?

The Blood Typing Market accounted for USD 2.23 Billion in 2024 and USD 2.43 Billion in 2025 is expected to reach USD 5.61 Billion by 2035, growing at a CAGR of around 8.75% between 2025 and 2035. The blood typing market is a vital component of healthcare because it is critical in guaranteeing safe blood transfusions, organ transplants, and maternal-fetal medicine. It entails techniques and kits that determine blood groups, depending on the antigens found on red blood cells, and thereby prevent the life-threatening transfusion reactions. The increase in the knowledge of safe transfusion practices and the necessity of early awareness of the disorders connected with the blood are stimulating the demand for accurate and fast blood typing solutions. Automated analyzers, point-of-care testing kits, and molecular tests with improved precision and speed are emerging in the market.

The increasing number of chronic illnesses and the use of surgery also emphasize the need for blood typing in a clinical environment. Its relevance is also growing through the use of blood typing in the areas of forensic science and research. Moreover, the use of modern typing systems is becoming more popular in blood banks and hospitals because of their efficiency and safety for patients. As the world advances in technologies and TV focuses on improved healthcare infrastructure, the blood typing market is ever-growing in these regions.

What do industry experts say about the Blood Typing market trends?

“Transitioning from serologic methods to DNA-based genotyping enhances blood compatibility assessments.”

• Dr. Marion Reid, Immunohematologist and Former Director, Laboratory of Immunohematology, New York Blood Center

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Blood Typing market?

How is demand for safe blood transfusions driving market growth?

The rising need to get safe blood transfusions is also a major factor in the blood typing market. Transfusion of blood is necessary in numerous cases, such as in anemia, trauma, surgeries, complications during pregnancy and childbirth, etc. According to the World Health Organization (WHO), it is estimated that almost 120 million units of blood are donated each year across the world, but this is not enough to satisfy the global demand, especially in low- and middle-income nations. The regions usually have difficulties in ensuring a constant supply of safe blood because of the low rate of donation and the accessibility to screening technologies.

High-income countries have a median blood donation rate of 31.5 donations per 1,000 people, whereas low-income countries have a median blood donation rate of 5.0 donations per 1,000 people. Such a difference highlights the high urgency of dependable blood typing technologies to guarantee the safety and compatibility of transfusion. With the increasing demand for blood products through the healthcare systems, the development of blood typing technologies is essential to improve the efficiency and safety of the transfusion practices.

How does rising chronic disease prevalence increase blood typing requirements?

The increase in prevalence of chronic diseases has a tremendous impact on the demand for blood typing market services. Chronic anemia, heart diseases, and chronic renal disease are the diseases that usually require frequent blood transfusions, and accurate blood typing is a must. An example of this is a study conducted in Italy, where 29.8% of the blood transfusions within the emergency department were given to patients with chronic anemia, and this is the reason why the blood products are constantly needed in this group of patients.

The World Health Organization informs that in highly developed countries, patients who are above 60 years old make up as many as 76 percent of all transfusions, and most of them have a chronic illness that needs continuous medical attention. These statistics reinforce the importance of blood typing to guarantee the safety and compatibility of transfusion in patients with chronic conditions. With the current and ever-growing global burden of chronic diseases, it is observed that the need for the blood typing market to have the correct and efficient blood typing technologies will continue to increase.

How does the high cost of automated systems limit adoption globally?

Automated blood typing systems are expensive, and this is a key limitation to the blood typing market. High-end equipment, such as automated analyzers and molecular testing platforms, is expensive in terms of capital expenditure, which is prohibitive to smaller hospitals, clinics, and laboratories, particularly in the developing world. Besides the initial costs of purchases, there are continuous costs of maintenance, software upgrades, and special reagents, which add to the cost burden. This constrains the adoption of such technologically advanced systems in wide use, even though they are more accurate and quicker to process than the traditional ones.

The budget constraint in many healthcare centers is still limiting the use of automated or semi-automated testing procedures. This has led to the continued concentration of the use of state-of-the-art blood typing technology in high-income nations and in large metropolitan medical hubs. This economic obstacle impedes the overall development of the market, and there is a lack of unequal access to better diagnostic opportunities around the world. The question of affordability must be addressed, and relatively cost-effective solutions must be developed to increase the market in resource-constrained areas.

How is automated blood typing adoption creating growth opportunities globally?

The blood typing market has a huge growth potential with the rising use of automated systems of blood typing. Automated systems are more accurate, quicker in processing, and lower in human error than non-automated methods, and therefore are very appealing to hospitals, blood banks, and diagnostic laboratories. These technologies facilitate work, and a significant amount of blood samples can be analyzed in a labor-saving manner, which is particularly useful in the healthcare environment with high requirements.

The need to use advanced solutions to enhance patient safety and reliability of transfusion is increasing, as well as the number of healthcare facilities striving to increase the quality of services and procedures. Furthermore, automation makes it possible to connect with laboratory information systems, enhance data management, and trackability. The automated blood typing is starting to be valued in emerging markets, and this creates a possibility of further growth beyond high-income nations. The market opportunities are further boosted by the ongoing production of automated analyzers that can be easily used and are cost-effective. In general, the technological advancement and the expansion of the market are stimulated by automated blood typing systems.

How does prenatal and neonatal care expansion increase blood typing demand?

The growth of prenatal and neonatal care offers great potential to the blood typing market. Blood typing has become paramount in pregnancy care, especially to avoid the hemolytic disease of the newborn occurring as a result of Rh incompatibility between the mother and the child. Regular blood group screening of pregnant mothers in prenatal checkups is used to detect risk factors at a tender age so that medical care can be given at the right time. Similarly, proper blood typing is needed to perform transfusion safely on premature or critically ill infants in neonatal care, which in most cases requires various blood products. Due to the growth of the services and focus on preventative healthcare provided in hospitals and maternity care centers, the need to find a credible blood typing solution is rising. The introduction of new technology, including rapid and point-of-care testing, also helps with effective screening during prenatal and neonatal practice. Such increased interest in maternal and infant health promotes the necessity of an accurate, rapid, and safe blood typing technology, which generates substantial growth opportunities in this market.

What are the key market segments in the Blood Typing industry?

Based on the Type, the Blood Typing Market is classified into Blood Typing Reagents, Blood Typing Kits, Blood Typing Instruments, Services, and Others. This market is top because the reagents are needed in determining the blood groups accurately, and they are applied during the process of blood typing, whether in hospitals, blood banks, or in a diagnostic laboratory, in nearly all procedures. Monoclonal and polyclonal antibodies are reagents that enable easy and accurate identification of antigens on blood cells, which are essential to safe blood transfusions and organ transplantations. They are also largely used in both standard and specialty testing, including prenatal and forensic testing, which further endorses their market dominance.

Testing accuracy and efficiency have been enhanced by continuous innovation in reagent formulations with enhanced stability and increased sensitivity. Costs of blood typing reagents are also relatively lower than those of more sophisticated instruments, making those reagents applicable in a wide range of healthcare facilities, including smaller facilities. Moreover, there is a growth in surgeries, transfusions, and chronic diseases around the world, which drives the constant need for such reagents. Generally, the blood typing reagents market is still pivotal in the market because of its indispensability, reliability, and extensive applications in both clinical and research settings.  

Based on the Technology, the Blood Typing Market is classified into Blood Typing Reagents, Serological Testing, Gel Card Technology, Molecular Testing, Microarray-based Testing, Automated Blood Typing Systems, and Others. Serological Testing is the most powerful technology in the blood typing market. The technique has, in the past decades, been employed extensively owing to its simplicity, reliability, and cost-effectiveness. It entails a procedure of identifying antigens on red blood cells using particular antibodies to obtain precise results in routine blood typing in hospitals, blood banks, and diagnostic laboratories.

The serological type of testing is very desirable due to its quick turnaround time, convenience to use, and low equipment needs, which can be used on a large scale as well as in point-of-care settings. The procedure is also able to function with a large variety of test forms, such as slide, tube, and microplate, and further improves its flexibility. Its supremacy is also enhanced by the fact that it has already developed infrastructure and trained staff familiar with serological processes. Although newer technologies such as molecular and automated systems are on the rise, serological testing still takes care of most of the blood typing processes in the world. This is because its accuracy, accessibility, and cost make it the mainstay of blood typing in clinical and research activities.

Which regions are leading the Blood Typing market, and why?

The North American blood typing market is marked by a high level of healthcare facilities and high uptake of new diagnostic methods. Automated systems and molecular techniques are replacing in-house tests in hospitals, blood banks, and diagnostic laboratories in the region to provide faster and more accurate results. The increasing attention to patient safety and the strict regulations framework has promoted the application of standardized blood typing practices. Increasing numbers of surgical operations and the need to transfuse patients have also increased the pressure on finding quality testing solutions.

The role of blood typing is also growing in the region, with contributions by research institutions and forensic applications. The availability of qualified medical personnel helps in the incorporation of modern diagnostic instruments in the daily practices of medicine. Agreement to preventive health and early detection is a way to raise the levels of adoption in the market. On the whole, the region stands to play a leading role in technological advancement and to establish the international standards of blood typing practice.

The Asia Pacific blood typing market is experiencing a slow but steady growth towards its potential, owing to increasing healthcare infrastructure and increasing awareness of safe blood transfusions. The rising number of hospitalizations, surgeries, and high rates of chronic diseases are fueling the need for dependable solutions to blood typing. The technology of automated analyzers and point-of-care testing systems is being slowly embraced by the countries in the region to enhance efficiency and accuracy. Modern technologies are being invested in by blood banks and diagnostic laboratories in order to satisfy the increasing demands of patients.

Market growth is further supported by government programs and healthcare programs that are geared towards enhancing safety in transfusion. There is also a high number of patients in the region, and this factor promotes the emergence of sophisticated diagnostic services. Nonetheless, obstacles like the shortage of skilled staff and high expenses in some regions can influence the rates of adoption. In general, the Asia Pacific market has a bright prospect since healthcare awareness and infrastructure have been improved.  

What does the competitive landscape of the Blood Typing market look like?

The blood typing market is very competitive all over the world, and there are some major market players that control the innovation and market share. Innovation leaders such as Grifols, Bio-Rad Laboratories, and Ortho Clinical Diagnostics are leading in terms of diversification of their products and the emergence of superior blood typing mechanisms. Such firms are also improving their geographical reach through strategic alliances and partnerships. Siemens Healthineers, Abbott Laboratories, and Beckman Coulter, Inc. are other market players of prominence.

Such companies are taking advantage of their established customer bases to invest in sophisticated technology and infrastructure to handle and analyse a massive number of samples efficiently. Also, other companies like Immucor, Inc., Thermo Fisher Scientific, and Merck KGaA are making contributions to the expansion of the market because they are concentrating on their research and development to launch new products and solutions. Their work is to enhance the accuracy and efficiency of blood typing processes to support the growing demand for safe and reliable blood transfusions.

Blood Typing Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Blood Typing industry?

• In May 2024, Thermo Fisher Scientific launched the Applied Biosystems Axiom BloodGenomiX Array and Software, a high-throughput solution that improves blood genotyping accuracy. The platform allows simultaneous detection of extended and rare blood groups, as well as HLA and HPA types, in clinical research.

Report Coverage:

By Product Type

• Blood Typing Reagents
• Blood Typing Kits
• Blood Typing Instruments
• Services
• Others

By Technology

• Serological Testing
• Gel Card Technology
• Molecular Testing
• Microarray-based Testing
• Automated Blood Typing Systems
• Others

By Sample Type

• Whole Blood
• Red Blood Cells
• Plasma
• Serum
• Others

By Application

• Transfusion Medicine
• Organ Transplantation
• Forensic Science
• Prenatal Testing
• Disease Screening
• Others

By End-User

• Hospitals & Clinics
• Diagnostic Laboratories
• Blood Banks
• Research & Academic Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Ortho Clinical Diagnostics
• Abbott Laboratories
• Bio-Rad Laboratories
• Grifols S.A.
• Thermo Fisher Scientific
• Immucor, Inc.
• F. Hoffmann-La Roche Ltd
• DiaMed GmbH
• BioMérieux SA
• Siemens Healthineers
• MacoPharma
• Shinwoo Holdings Co., Ltd.
• Terumo Corporation
• Stago Group
• Randox Laboratories

Frequently Asked Questions (FAQs)